Welcome to the New Pharma Models Blog

The design of pre-clinical studies is a complex task, and understanding the translation from animal model to human diseases requires a great deal of care and a high level of understanding of both the basic science and the clinical condition. Many drugs in clinical development flounder due to lack of efficacy or unacceptable side effects. The challenge of translating in vivo animal model results into clinical efficacy has been particularly difficult in the field of cancer research.

At Pharma Models, we pursue research for a variety of medical conditions including cancer, diabetes, inflammatory diseases, and obesity. We custom design studies for our clients to ensure their needs are met throughout the pre-clinical research process. Additionally, our organization is wholly owned by scientists that work for you and ensure affordable services along the way.

Whether you need assistance with tumor models, animal models of inflammatory diseases, obesity, diabetes, or toxicology and pharmacology, Pharma Models provides the services necessary to design effective, customized pre-clinical studies. With the goal of managing the majority of pre-clinical drug discovery needs, this blog is meant for educating our readers on major news evolving within the pharmaceutical industry as well as the importance of outsourcing tailored strategies for pre-clinical drug development.

Additionally, this blog will be used to inform our audience on topics relevant to the scientific expertise necessary for drug discovery. If you are interested in learning more about molecular biology, virology, pre-clinical trial design, oncology, antibody engineering, or pharmacology, this is the right place for you.

The Pharma Models blog is aimed toward providing the information necessary to learn about tailoring pre-clinical studies based on the needs of your research. We hope to engage a community of professionals who are looking to integrate outsourced drug discovery services and meet the needs of the pharmaceutical industry. We welcome you to continue following our news about the constantly changing field of drug development and pre-clinical design.